Related Experiment Videos
Medulloblastoma: treatment results and effect on normal tissues
Cancer
|March 1, 1979
Summary
Higher radiation doses (over 5000 rads) improved survival for children with medulloblastoma. Re-irradiation showed promising results, but craniospinal irradiation impacted immune and endocrine systems.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Neuro-oncology
Background:
- Medulloblastoma is a common pediatric brain tumor.
- Long-term effects of radiation therapy in children require careful evaluation.
Purpose of the Study:
- To retrospectively analyze treatment outcomes for pediatric medulloblastoma patients.
- To investigate the relationship between radiation dose and local control.
- To assess the impact of craniospinal irradiation on patient health.
Main Methods:
- Retrospective study of 33 children treated between 1962 and 1976.
- Analysis of radiation doses, survival rates, and failure sites.
- Evaluation of hematopoietic, immune, and endocrine system effects post-irradiation.
Main Results:
- Doses >5000 rads to the posterior fossa correlated with improved five-year survival.
- Posterior fossa and spinal cord were common failure sites.
- Re-irradiation yielded encouraging results with no significant complications.
- Craniospinal irradiation led to decreased lymphocyte counts and suggested functional impairment.
- Observed side effects included hypothalamic-pituitary axis suppression and brain necrosis.
Conclusions:
- Higher radiation doses may improve outcomes in pediatric medulloblastoma.
- Re-irradiation is a viable option for treatment failure.
- Craniospinal irradiation necessitates monitoring for immune and endocrine toxicities.